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Telah dilakukan penelitian penggunaan antibiotik profilaksis, 
sulbenisilin dibandingkan amoksisilin dan kalium klavulanat injeksi. Penelitian 
dilakukan secara retrospektif pada pasien yang melahirkan secara seksio 
sesarea dan mendapatkan sulbenisilin atau coamoxiclav injeksi di PKU 
Muhammadiyah Yogyakarta. Data diambil dari tanggal 1 Januari 2000 sampai 
dengan 31 Desember 2000. Langkah-langkah penelitian meliputi pencatatan 
data mengenai identitas pasien, indikasi dilakukan bedah sesar, jenis irisan 
abdominal dan antibiotik yang digunakan. Data yang terkait dengan biaya 
meliputi pemakaian obat dan alat operasi, biaya obat, biaya perbekalan 
farmasi, waktu yang diperlukan perawat untuk memberikan obat, dan biaya 
untuk mengatasi komplikasi yang terjadi. 
Dari 98 catatan medik yang terkumpul dilakukan analisis cost- 
minimization. Hasil penelitian menunjukkan lama hari perawatan pasien yang 
mendapatkan sulbenisilin injeksi adalah 4,85 hari dan pada pasien yang 
mendapatkan amoksisilin dan kalium klavulanat 4,90 hari. Dari perhitungan 
didapatkan biaya total rata-rata penggunaan sulbenisilin injeksi per hari lebih 
kecil, yaitu Rp.140.509, dibandingkan dengan amoksisilin dan kalium 
klavulanat, yaitu Rp. 376.310. 
Hasil penelitian ini diharapkan dapat memberikan manfaat, yaitu 
sebagai masukan pada klinisi untuk mengambil keputusan dalam 
penggunaan antibiotik pada seksio sesarea, bahan masukan bagi Komite 
Farmasi dan Terapi dalam merevisi Formularium Rumah Sakit dan 
penyusunan Pedoman Penggunaan Antibiotik dan bahan masukan bagi 
rumah sakit untuk menentukan Kebijakan Obat Rumah Sakit. 




The cost of antibiotic prophylaxis sulbenicillin versus coamoxiclav (in 
term of medication use and treatment of complications) to treat cesarean 
section was compared. 
The medical records of patient receiving intravenous sulbenicillin or 
coamoxiclav for the treatment of cesarean section in PKU Muhammadiyah 
Hospital were retrospectively reviewed. Data were collected for patients 
treated from January 1, 2000 to December 31, 2000. Patient data collected 
included patient data based, indication of cesarean section, abdominal 
incision and oral antibiotics. Cost data collected included drug acquisition 
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cost, cost of drug supplies, nursing time to administer the agents and cost of 
managing complication. 
The medical records of 98 patients were identified and reviewed. The 
average length of stay was 4.85 days for the sulbenicillin group and 4.90 
days for the coamoxiclav group. The average total including the cost of 
complication was Rp. 140.509 in sulbenicillin group and Rp. 376.310 in 
coamoxiclav group. 
In conclusion, the study demonstrates that intravenous coamoxiclav 
has a higher cost than that of intravenous sulbenicillin. This result can be 
used to assist institution, clinicians and pharmacists in determining the most 
appropriate and efficient use of drugs. These data can be a powerful tool to 
support various clinical and policy drug use decisions, for example included 
formulary management and drug use policy or guidelines. 
Key words: antibiotics, cesarean section, cost. 
 
Introduction 
The demand for and hence the cost of 
health care are increasing in all countries in the 
world as the improvement and sophistication 
of health technologies increase. Many govern-
ments are focusing their activities on 
promoting the effective and economic use of 
resources allocated to health care. The 
increased use of evidence-based programmes 
not only concentrates on optimising health 
outcomes but also utilities health economic 
evaluation (Evans and Hurley, 1995). 
Economic evaluation techniques were 
designed to help decision makers to ensure that 
scarce public resources are used to obtain the 
greatest possible social benefit. The similar 
term of health economic evaluation is 
Pharmacoeconomics. Pharmacoeconomics can 
be defined as the measurement of both the cost 
and consequences of therapeutic decision-
making. Pharmacoeconomics provides a guide 
for decision makers on resource allocation but 
does not offer a basis on which decisions 
should be made(Bootman et al., 1996). 
Cesarean section is defined as the birth 
of the fetus through incisions in the abdominal 
wall and the uterine wall. Although cesarean 
delivery can be regarded as a reasonably safe 
surgical procedure, it is associated with higher 
risks of morbidity and mortality than vaginal 
delivery. For the past 20 years, interest in the 
perioperative and prophylactic use of anti-
biotics for cesareaan section has been stimu-
lated by a number of events, including the high 
rate of postoperative infections, the recent 
increase in the rate of cesarean section and the 
success of infection prophylaxis in vaginal 
hysterectomy (Cunningham et al., 1997). 
The antibiotics chosen for prophylaxis 
for gynaecologic surgery should have activities 
against the broad range of vaginal organism. 
The first and second generation cephalos-
porins are well suited for this purpose because 
of their activity against gram-positive, gram-
negative, and anaerobic organism. Most classes 
of antibiotics (including penicillin, tetracycline, 
sulfonamide, broad spectrum penicillin, and 
cephalosporins) and anaerobic drugs have been 
shown to be as effective as prophylactic anti-
biotics(Jarning and Rybak, 1997). 
American Medical Association reviewed 
that cefoxitin, cefotetan, third generation 
cephalosporins and extended spectrum 
penicillin have been shown to be effective for 
prophylaxis of cesarean section. (Briceland and 
Guglielmo, 1996) In PKU Muhammadiyah 
Yogyakarta Hospital, the majority of antibiotics 
prophylaxis for cesarean section referred to 
2000 was IV sulbenicillin and coamoxiclav. The 
purpose of this study was to compare costs of 
IV sulbenicillin and coamoxiclav (in term of 
medication use and treatment of compli-
cations). We conducted a cost-minimization 
analysis from an institutional perspective. 
 
Methodology 
We conducted a retrospective review of the 
medical records of patients receiving intravenous 
(iv) sulbenicillin or coamoxiclav for cesareaan 
section. Patients were identified through the 
pharmacy computer database. Data were collected 
for patient treated from January 1, 2000 to 
December 31, 2000 in the gynaecologic and 
obstetric division  PKU Muhammadiyah Hospital 
Yogyakarta. Patients were included if they admitted 
for cesarean section, admitted to economic class and 
received iv sulbenicillin or coamoxiclav. Patients 
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were excluded if they received combination IV 
antibiotics therapy. 
Patient data collected included baseline 
demographics (maternal age, indication prior 
cesarean section, the type of abdominal incision and 
weight birth), antimicrobial dosage and dosage 
interval. Because this was a retrospective review, 
adverse effects were not evaluated. The compli-
cation was documented from medical record if 
occurs draining wound or presence of pus after 
discharge from the hospital. 
Cost data included drug acquisition cost, 
nursing time to administer the agent, cost of drug 
supplies and cost of managing complications. In our 
study, the Pharmacy cost of drug preparation was 
not included, because  the drug was prepared by the 
same time in all patients.  
All evaluation was carried out from the 
hospital perspective and the cost was referred to 
2000, the year in which the trial was conducted. We 
evaluated direct cost per patient after cesarean 
section related to iv antibiotic treatment and mean 
cost of complication. 
The cost of iv therapy was calculated by 
summing the acquisition cost of drugs and the cost 
of both materials used and the time spent by nursing 
staff to administer the therapy. The cost of drugs 
and materials were evaluated using hospital 
acquisition prices. 
The cost of nursing time was calculated by 
using an average nursing salary of Rp 3.500 per hour 
(average of Sakinah ward nurse’s; the salaries were 
obtained from Administrative Department). Time to 
administer the medication was determined by 
polling Sakinah ward nurse’s about the time taken to 
administer these iv medications. 
The cost of treating complications (i.e. 
presence of pus or wet wound ) included the cost of 
drugs and materials to treat the complication. 
Using student’s t test compared continuous 
variables. The chi-square test was used to compare 
categorical variables between the two groups. 
 
Results and Discussion 
The medical records of 98 patients who 
received iv sulbenicillin or coamoxiclav were 
identified and reviewed. Seventy-seven patients 
(78,6%) received iv sulbenicillin and 21 patients 
(21,4%) received iv coamoxiclav (table I).         
Prophylactic antibiotics are used widely 
in surgical procedures and account for up to 50 
% of total antibiotic usage in many hospitals. 
The purpose  of surgical antibiotic prophylaxis 
is to reduce the prevalence of postoperative 
wound infection at or around the surgical site. 
Appropriate Prophylactic antibiotics can reduce 
the incidence of postoperative infection by 50– 
70..% as documented by controlled clinical 
trials. Administration of prophylactic antibiotics 
in certain surgical procedures can decrease 
postoperative infections, decrease length of 
hospital stay, and reduce the overall cost of 
care. 
Antibiotic prophylactic in cesarean 
section should be limited to patients at high risk 
for infectious disease. Only a short periopera-
tive course of antibiotics should be adminis-
tered and continuing for one or two 
postoperative doses at 6-hour intervals. In our 
study, patient received 4 to 6 postoperative 
dose at 8 to 12 hour intervals. 
Table II showed that the maternal age of 
33,8% (26 of 77) patients in iv sulbenicillin 
group were 25 to 29 years old and 47,6% (10 of 
21) in the coamoxiclav group. 
 Table II. Distribution of age 
  
Sulbenisilin coamoxiclav Total 
Maternal age 
number % number % number % 
15 - 19 3 3,8 - - 3 3,0 
20 - 24 12 15,6 3 14,3 15 15,3 
25 - 29 26 33,8 10 47,6 36 36,8 
30 - 34 20 26,0 5 23,8 25 25,5 
35 - 39 16 20,8 3 14,3 19 19,4 
Total 77   21   98 100 
 
Table I.  Distribution  of  intravenous  antibiotics  
.usage 
 
Antibiotics number % 
Sulbenisilin   77 78,6 
coamoxiclav 21 21,4 
Total   98 100 
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In general, the indication for cesarean 
section is any situation in which delivery of the 
fetus must be accomplished and  in which 
induction of labor, a trial labor, additional 
labor, or vaginal delivery of the fetus is deemed 
to be of greater risk to the mother or the fetus 
than abdominal delivery. Our study demons-
trates that the most frequent indication for 
cesarean section is dystocia or failure to 
progress in labor (Table III). 
Trial of labor in patients with a vertical 
abdominal incision for cesarean section was 
53,1% and 46,9% with a fannenstiel (table IV). 
The advantages of the transverse uterine 
incision over the vertical uterine incision for 
cesarean section, that low vertical incision 
almost always extend into the thicker muscle 
layers of the fundus and are more frequently 
complicated by improper healing and sub-
sequent rupture. Also when the entire uterine 
incision can be covered by the bladder 
peritoneum there is less risk of postoperative 
ileus, peritonitis, and subsequent adhesions and 
bowel obstruction.  
Our study demonstrates that the most 
common weight birth between two groups was 
3000 – 3499 gram. The differences about 
maternal age, indication for cesarean section, 
the type of abdominal incision, and weight 
birth between two groups were no significant. 
Choosing an antimicrobial agent to treat 
or prevent an infection is far more complicated 
than simply matching a drug to known or 
suspected pathogens. The medication order 
form recorded 50 % of the oral antibiotics  
administered after the iv antibiotics stopped 
was amoxicillin. Selection of antimicrobial 
therapy is nearly always empiric and based on 
drug of choice for the treatment of most 
pathogens. 
As efforts to minimize health care cost 
increase, it is essential to look beyond drug 
acquisition costs and consider others factors 
involved in drug therapy, included drug 
Table III. Indication for cesarean section 
 
Indication Sulbenisilin coamoxiclav Total 
  number % number % number % 
Serotinus 5 6,5 3 14,3 8 8,2 
KPD 14 18,2 2 9,6 16 16,3 
Breech 8 10,4 5 23,8 13 13,3 
Proven cephalopelvic  
disproportion 10 13,0 1 4,7 11 11,2 
dystocia 16 20,7 6 28,6 22 22,4 
Preeklamptia 7 9,1 1 4,7 8 8,2 
Placenta previa 11 14,3 2 9,6 13 13,2 
others 6 7,8 1 4,7 7 7,1 
Total 77   21   98 100 
 
Table IV. Type of incision 
 
Sulbenisilin coamoxiclav Total 
Type of incision 
number % number % number % 
 Vertical 45 58,4 7 33,3 52 53,1 
 Fannenstiel 32 41,6 14 66,7 46 46,9 
Total 77   21   98 100 
 












sulbenicillin Rp.133.550 Rp.17.809 Rp.   800 Rp.  8.350 Rp.140.509 
coamoxiclav Rp.332.850 Rp.22.010 Rp.1.690 Rp.19.760 Rp.376.310 
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preparation, drug administration dosage 
frequency and patient tolerability. Although 
drug acquisition cost is a substantial compo-
nent of the total cost of drug therapy, the 
additional factor previously mentioned can 
have a substantial impact on total cost. 
All evaluation was carried out from the 
hospital perspective. Cost-minimization analysis 
is used to compare alternative intervention for 
the same disease or condition where it can be 
proved that the alternatives have identical 
outcomes. The option, which is the least costly, 
is the most efficient. 
In our study, we attempted to account 
for the major components contributing to the 
total cost of drug therapy. Our result should be 
viewed with caution because of the 
retrospective nature of study would provide 
more accurate information in term of patient 
tolerability and other confounding factors that 
may contributes to adverse effects. 
The cost of nursing time was calculated 
by using an average nursing salary multiplied by 
the time to administer the medication. From 
data obtained by administrative department, the 
mean cost per hour per worker in the medical 
obstetric and gynaecology division (sakinah 
ward) was obtained by dividing the total annual 
(2000) cost of nursing staff by the number of 
hours worked by each group in the same year. 
This cost was Rp 3500 (Rp 60/minute). In our 
study, the average cost to administer iv 
sulbenicillin was Rp 800 and Rp 1.690 for iv 
coamoxiclav. 
The dose of iv sulbenicillin therapy was 
1 gram three times daily for about two days and 
for iv coamoxiclav was 1 gram twice daily for 
about three days. As sulbenicillin is available in 
vials containing 1 gram (hospital acquisition 
price Rp 18.925). Therefore, the average of 
intravenous sulbenicillin acquisition cost for 
each patient would be Rp 18.925/vial x 3 x 2 
days = Rp. 113.550. The average of intravenous 
coamoxiclav acquisition cost for each patient 
would be Rp..55.475/ vial x 2 x 3 days = 
Rp..332.850. 
To administer iv sulbenicillin, 5..ml 
syringe (Rp..2.965) was needed. For iv 
coamoxiclav, 10 ml syringe (Rp 3.665) was 
needed. All these prices were obtained from the 
hospital pharmacy. Cost of intravenous sets 
and needles for the administration of drugs 
were not included, because antibiotics were 
administered using the same equipment. 
The cost of treating complications 
(presence of pus or wet  wound) included the 
cost of drugs and materials were Rp 8.350 for 
iv sulbenicillin group and Rp 19.760 for 
coamoxiclav group. 
The mean total days of therapy were 
4,85 for the iv sulbenicillin group and 4,90 for 
the coamoxiclav group. There were no 
significant differences between groups 
(p=0,05). The average total cost, including the 
cost of complication was Rp.140.509 (over 4,85 
days) in the iv sulbenicillin group and 
Rp.376.310 (over 4,90 days) in the coamoxiclav 
group. It was suggested that the cost of drug 
acquisition, drug supplies, administration cost 
and complication cost for coamoxiclav was 
greater than for sulbenicillin. 
 
Limitation 
Given that our evaluation was retros-
pective, it is important to consider other factors 
that may have biased our result. Although both 
sulbenicillin and coamoxiclav are associated 
with other adverse effects ( e.g. hypersensitivity 
reactions and irritation of the gastrointestinal 
tract ), we focused only on complication. 
We did not consider cost associated with 
any potential  therapy used for phlebitis or 
thrombophlebitis, nor did we consider the 
impact of these adverse effects on nursing time. 
Because this was a retrospective study, we have 
no information about the patient perspective 
on the treatment regimens. Factors such as 
discomfort due to phlebitis and the potential 
inconvenience of dosage intervals are important 
to consider in the choice of optimal drug 
therapy. 
Although pharmacoeconomic data are 
always interesting and sometimes compelling, 
they need to be interpreted in terms of the 
specific clinical context being addressed before 




The combined drug acquisition, drug 
supplies, administration cost, and complication 
cost for coamoxiclav was greater than that for 
sulbenicillin. 
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